HCM is a relatively common genetic cardiomyopathy that can be a challenge to diagnose, with about one in three patients misdiagnosed as having another cardiomyopathy. Genetic testing identifies a ...

2. The AI-powered ECG predicts the likelihood of patients having heart conditions including amyloidosis, atrial fibrillation and hypertrophic cardiomyopathy. 3. A computer vision-based smartphone app ...

A study has found that aficamten is associated with improvements across a range of clinical outcomes in patients with obstructive hypertrophic cardiomyopathy.

Background: Symptoms are among the most important factors impacting quality of life (QOL) in hypertrophic cardiomyopathy (HCM) patients, and reflect a poor prognosis. Whether emotional stress can ...

Cardiovascular disease, sometimes abbreviated as CVD, is the leading cause of death worldwide. It’s a catchall term for heart ...

"Cardiomyopathy" is an umbrella term for diseases of the heart muscle that negatively impact its structure and ...

Background: Microvascular dysfunction is a hallmark of hypertrophic obstructive cardiomyopathy (HOCM). Factors modulating myocardial microcirculation in response to disease phenotype require further ...

Background: Hypertrophic obstructive cardiomyopathy (HOCM) is a genetic disorder characterized by thickened heart muscle and dynamic left ventricular outflow tract (LVOT) obstruction. Mavacamten ...

Background: Patients who receive appropriate implantable cardioverter defibrillator (ICD) shocks have a subsequent adverse prognosis. Most data suggest that patients with inappropriate ICD shocks ...

dsmc.or.kr Objective Apical hypertrophic cardiomyopathy (HCM) is characterised by apical systolic obliteration and is associated with atrial fibrillation (AF), stroke, heart failure (HF), and ...